Zhao Xu
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Microchromosome maintenance protein 2 is essential in immune infiltration-correlated prognosis of multiple myeloma patients by regulating cell cycle.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: December 15, 2025
EPAS1 increases SDHA to inhibit proliferation of multiple myeloma cells by restoring TCA Cycle.
Journal: NPJ precision oncology
Published: February 20, 2025
Synthetic macrolides overcoming MLSBK-resistant pathogens.
Journal: Cell discovery
Published: April 18, 2024
The role of KIAA1191 in the necroptotic pathway of multiple myeloma.
Journal: Annals of hematology
Published: March 21, 2021
High Expression of Succinate Dehydrogenase Subunit A Which Is Regulated by Histone Acetylation, Acts as a Good Prognostic Factor of Multiple Myeloma Patients.
Journal: Frontiers in oncology
Published: May 19, 2020
Suppression of CXCL-1 Could Restore Necroptotic Pathway in Chronic Lymphocytic Leukemia.
Journal: OncoTargets and therapy
Published: April 18, 2020
Correction to: MGUS Predicts Worse Prognosis in Patients with CoronaryArtery Disease.
Journal: Journal of cardiovascular translational research
Published: March 29, 2020
Globular C1q Receptor (gC1qR/p32/HABP1) Suppresses the Tumor-Inhibiting Role of C1q and Promotes Tumor Proliferation in 1q21-Amplified Multiple Myeloma.
Journal: Frontiers in immunology
Published: December 31, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026